Datopotamab Deruxtecan in Advanced or Metastatic Non-Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study.

待确认 100 由医休发布于 2026/6/27 12:35:35

DOI:10.1200/JCO-24-01349
作者：Jacob Sands,?Myung-Ju Ahn,?Aaron Lisberg,?Byoung Chul Cho,?George Blumenschein,?Elaine Shum,?Elvire Pons Tostivint,?Yasushi Goto,?Kiyotaka Yoh,?Rebecca Heist,?Junichi Shimizu,?Jong-Seok Lee,?Paul Baas
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1200/JCO-24-01349

American Society of Clinical Oncology (ASCO)

Abstract：Purpose: Datopotamab deruxtecan (Dato-DXd) is a trophoblast cell-surface antigen-2-directed antibody-drug conjugate with a highly potent topoisomerase I inhibitor payload. The TROPION-Lung05

应助信息

等待求助人确认

求助人未确认前，本求助不能再次应助。36小时后系统将自动确认应助成功。本求助将自动关闭。

44分钟前

大寒

202606271621242225196.pdf

4小时前

Book学术机器人

2026/6/27 12:35:36 未找到该文献，机器人已退出，请等待人工下载

2026/6/27 12:35:35 Book学术AI机器人收到请求，开始寻找文献

2026/6/27 12:35:35 已向机器人发送请求

4小时前

医休发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:WileyMacrophage Plasticity and Immune Remodeling in Ischemic Heart Failure.